NovaBay Pharmaceuticals NBY Stock
NovaBay Pharmaceuticals Price Chart
NovaBay Pharmaceuticals NBY Financial and Trading Overview
| NovaBay Pharmaceuticals stock price | 1.95 USD |
| Previous Close | 1.59 USD |
| Open | 1.58 USD |
| Bid | 0 USD x 30000 |
| Ask | 0 USD x 20000 |
| Day's Range | 1.57 - 1.98 USD |
| 52 Week Range | 1.11 - 99.75 USD |
| Volume | 626.37K USD |
| Avg. Volume | 462.47K USD |
| Market Cap | 51.92M USD |
| Beta (5Y Monthly) | 0.164 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -28.5 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | September 30, 2025 |
| 1y Target Est | N/A |
NBY Valuation Measures
| Enterprise Value | 45.09M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.378049 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.95 |
Trading Information
NovaBay Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.164 |
| 52-Week Change | -42.83% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 99.75 USD |
| 52 Week Low | 1.11 USD |
| 50-Day Moving Average | 2.16 USD |
| 200-Day Moving Average | 10.21 USD |
NBY Share Statistics
| Avg. Volume (3 month) | 462.47K USD |
| Avg. Daily Volume (10-Days) | 294.92K USD |
| Shares Outstanding | 26.63M |
| Float | 2.62M |
| Short Ratio | 0.69 |
| % Held by Insiders | 90.14% |
| % Held by Institutions | 5.34% |
| Shares Short | 333.12K |
| Short % of Float | 9.79% |
| Short % of Shares Outstanding | 1.28% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 350.09% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.10% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7578333 USD |
| Net Income Avi to Common (ttm) | -33222000 USD |
| Diluted EPS (ttm) | -28.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.96M USD |
| Total Cash Per Share (mrq) | 0.3 USD |
| Total Debt (mrq) | 776K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.596 |
| Book Value Per Share (mrq) | -0.919 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.7M USD |
| Levered Free Cash Flow (ttm) | -4935750 USD |
Profile of NovaBay Pharmaceuticals
| Country | United States |
| State | CA |
| City | Emeryville |
| Address | 2000 Powell Street |
| ZIP | 94608 |
| Phone | 510 899 8800 |
| Website | https://novabay.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Q&A For NovaBay Pharmaceuticals Stock
What is a current NBY stock price?
NovaBay Pharmaceuticals NBY stock price today per share is 1.95 USD.
How to purchase NovaBay Pharmaceuticals stock?
You can buy NBY shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NovaBay Pharmaceuticals?
The stock symbol or ticker of NovaBay Pharmaceuticals is NBY.
Which industry does the NovaBay Pharmaceuticals company belong to?
The NovaBay Pharmaceuticals industry is Biotechnology.
How many shares does NovaBay Pharmaceuticals have in circulation?
The max supply of NovaBay Pharmaceuticals shares is 26.63M.
What is NovaBay Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
NovaBay Pharmaceuticals PE Ratio is now.
What was NovaBay Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
NovaBay Pharmaceuticals EPS is -28.5 USD over the trailing 12 months.
Which sector does the NovaBay Pharmaceuticals company belong to?
The NovaBay Pharmaceuticals sector is Healthcare.
NovaBay Pharmaceuticals NBY included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE American Composite Index XAX | 8750.58 USD — |
-0.14
|
— — | 8749.41 USD — | 8844.17 USD — | — - | — — |
- {{ link.label }} {{link}}